- Home
- SLNH vs BOLT Comparison
SLNH vs BOLT Comparison
Compare SLNH & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNH
- BOLT
- Stock Information
- Founded
- SLNH 1961
- BOLT 2015
- Country
- SLNH United States
- BOLT United States
- Employees
- SLNH N/A
- BOLT N/A
- Industry
- SLNH EDP Services
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- SLNH Technology
- BOLT Health Care
- Exchange
- SLNH Nasdaq
- BOLT Nasdaq
- Market Cap
- SLNH 21.6M
- BOLT 22.6M
- IPO Year
- SLNH N/A
- BOLT 2021
- Fundamental
- Price
- SLNH $2.21
- BOLT $0.51
- Analyst Decision
- SLNH
- BOLT Hold
- Analyst Count
- SLNH 0
- BOLT 5
- Target Price
- SLNH N/A
- BOLT $1.25
- AVG Volume (30 Days)
- SLNH 395.8K
- BOLT 186.2K
- Earning Date
- SLNH 11-14-2024
- BOLT 11-12-2024
- Dividend Yield
- SLNH N/A
- BOLT N/A
- EPS Growth
- SLNH N/A
- BOLT N/A
- EPS
- SLNH N/A
- BOLT N/A
- Revenue
- SLNH $39,867,000.00
- BOLT $9,779,000.00
- Revenue This Year
- SLNH N/A
- BOLT $9.87
- Revenue Next Year
- SLNH N/A
- BOLT N/A
- P/E Ratio
- SLNH N/A
- BOLT N/A
- Revenue Growth
- SLNH 163.48
- BOLT 35.86
- 52 Week Low
- SLNH $1.40
- BOLT $0.48
- 52 Week High
- SLNH $8.80
- BOLT $1.56
- Technical
- Relative Strength Index (RSI)
- SLNH 43.38
- BOLT 41.39
- Support Level
- SLNH $1.83
- BOLT $0.50
- Resistance Level
- SLNH $2.20
- BOLT $0.55
- Average True Range (ATR)
- SLNH 0.25
- BOLT 0.04
- MACD
- SLNH 0.03
- BOLT -0.00
- Stochastic Oscillator
- SLNH 38.78
- BOLT 13.04
About SLNH Soluna Holdings Inc.
Soluna Holdings Inc is a U.S.-based company that conducts operations through its subsidiary. The group is engaged in the mining of cryptocurrency through data centers that can be powered by renewable energy sources. The data centers buy every excess megawatt to use for batch-oriented, computing-intensive processes such as cryptocurrency mining or machine learning which is a low-risk and low-friction solution to use as a smartphone.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.